A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer

Takaki Yoshikawa,Akira Tsuburaya,Ken Shimada,Atsushi Sato,Makoto Takahashi,Wasaburo Koizumi,Yasuo Yoshizawa,Kazuhito Nabeshima,Masayuki Kimura,Kiyoshi Hataya,Osamu Kobayashi

A phase II study of doxifluridine and docetaxel combination chemotherapy for advanced or recurrent gastric cancer

2009

Takaki Yoshikawa
Akira Tsuburaya
Ken Shimada
Atsushi Sato
Makoto Takahashi
Wasaburo Koizumi
Yasuo Yoshizawa
Kazuhito Nabeshima
Masayuki Kimura
Kiyoshi Hataya
Osamu Kobayashi

Background The aim of this study was to establish the efficacy and safety of doxifluridine and docetaxel for patients with advanced or recurrent gastric cancer.

Keywords:

Recurrent gastric cancer
Phases of clinical research
Medicine
Febrile neutropenia
Oral administration
Progression-free survival
Oncology
Doxifluridine
Docetaxel
Chemotherapy
Internal medicine
combination chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations